清道夫受体MARCO是肺部抵御肺炎球菌肺炎和吸入颗粒所必需的。
The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles.
作者信息
Arredouani Mohamed, Yang Zhiping, Ning YaoYu, Qin Guozhong, Soininen Raija, Tryggvason Karl, Kobzik Lester
机构信息
Physiology Program, Harvard School of Public Health, 665 Huntington Ave., SPH-II, Rm. 221, Boston, MA 02115, USA.
出版信息
J Exp Med. 2004 Jul 19;200(2):267-72. doi: 10.1084/jem.20040731.
Alveolar macrophages (AMs) express the class A scavenger receptor macrophage receptor with collagenous structure (MARCO), but its role in vivo in lung defense against bacteria and environmental particles has not been studied. We used MARCO-deficient mice to directly test the in vivo role of AM MARCO in innate defense against pneumococcal infection and environmental particles. In a murine model of pneumococcal pneumonia, MARCO(-/-) mice displayed an impaired ability to clear bacteria from the lungs, increased pulmonary inflammation and cytokine release, and diminished survival. In vitro binding of Streptococcus pneumoniae and in vivo uptake of unopsonized particles by MARCO(-/-) AMs were dramatically impaired. MARCO(-/-) mice treated with the "inert" environmental particle TiO(2) showed enhanced inflammation and chemokine expression, indicating that MARCO-mediated clearance of inert particles by AMs prevents inflammatory responses otherwise initiated by other lung cells. Our findings point to an important role of MARCO in mounting an efficient and appropriately regulated innate immune response against inhaled particles and airborne pathogens.
肺泡巨噬细胞(AMs)表达具有胶原结构的A类清道夫受体巨噬细胞受体(MARCO),但其在肺部抵御细菌和环境颗粒的体内作用尚未得到研究。我们使用MARCO基因缺陷小鼠直接测试AMs的MARCO在抵御肺炎球菌感染和环境颗粒的先天防御中的体内作用。在肺炎球菌肺炎的小鼠模型中,MARCO(-/-)小鼠清除肺部细菌的能力受损,肺部炎症和细胞因子释放增加,存活率降低。MARCO(-/-)AMs对肺炎链球菌的体外结合以及体内对未调理颗粒的摄取均显著受损。用“惰性”环境颗粒二氧化钛(TiO₂)处理的MARCO(-/-)小鼠表现出炎症增强和趋化因子表达,表明AMs通过MARCO介导的惰性颗粒清除可防止其他肺细胞引发的炎症反应。我们的研究结果表明,MARCO在针对吸入颗粒和空气传播病原体发起有效且适当调节的先天免疫反应中起重要作用。
相似文献
Am J Respir Cell Mol Biol. 2006-10
Toxicol Appl Pharmacol. 2007-8-15
Am J Physiol Lung Cell Mol Physiol. 2017-6-1
引用本文的文献
Immunother Adv. 2025-3-11
Pathogens. 2025-1-17
Adv Exp Med Biol. 2024
Immunohorizons. 2024-4-1
本文引用的文献
Toxicol Appl Pharmacol. 2003-6-1
J Biol Chem. 2002-9-6
Br Med Bull. 2002
Am J Respir Cell Mol Biol. 2002-4
Int Rev Cytol. 2002